Skip to content

ONCOLOGIX

Active Private limited companyfounded 2025active for 1 yearAlphonse De Wittestraat 50, 1050 IxellesKBO/BCE: BE 1027.890.093

Lifetime

1 annual account with figures
peak of €37,479 in 2025
€37,479 
peak of €29,775 in 2025
€29,775 
peak of €29,776 in 2025
€29,776 
€23,737 
Board1 name since 2025
1 director
Documentsfilings and deeds
28-08-202628 days late
2025micro format
Incorporation 23-091 establishment registeredFirst year with figures

Key points

from the 2025 annual accounts

Turnover

≈ €150,000 estimated

The micro format states no turnover.

2025 accounts filed 28 days after the deadline

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 11,279 companies had the same profile as ONCOLOGIX has now. Each dot stands for 29 companies, two years later.

96.6%
were still trading
2.6%
stopped another way
0.7%
went bankrupt
  • Micro
  • under 2 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 11,279 companies, not a prediction for ONCOLOGIX. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 18-09-2025
  • 100 sharesdeed of 23-09-2025
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:1027890093
Incorporation Founding capital of €1, 100 shares · Founded by · appointed as director · published on 23-09-2025 · Gazette deed
First establishment Alphonse De Wittestraat 50, Ixelles
All 4 events

Comparable companies

same main activity, similar in size and age
Company
ONCOLOGIX Ixelles €53,513 €37,479 55.6% -
ChiLi & Co Izegem €61,476 €53,263 64.1% 0
JIPPY Gembloux €77,252 €55,580 62.0% -
VKJ-Engineering Heist-op-den-Berg €41,764 €31,697 57.0% -
MZK Stekene €33,616 €21,495 56.9% -
HabeebeeCoop Namur €74,999 €33,679 -20.2% -
ABSOLINE Tournai €108,779 €65,615 59.7% -

These companies have the same main activity as ONCOLOGIX: other research and development on natural sciences (NACE 72109). They are comparable in size and age: total assets between €33,600 and €109,000, founded in 2025.

Official details

Source: KBO
Status
Active since 19-09-2025Normal situation
Activity
Other research and development on natural sciencesNACE 72109and 3 others
Establishment unit
2.379.467.9031050 Ixelles, since 19-09-2025
Financial year end
31 December
Peppol
Reachable since 24-10-2025
Company details

Annual accounts 2025

€53,513
Filing
Filed on 28-08-2026
Financials

Insights on ONCOLOGIX

ONCOLOGIX has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €29,776 and a net result of €29,775.

Its solvency ranks better than 46% of 667 sector peers (NACE 72) in financial year 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about ONCOLOGIX

What is the company number of ONCOLOGIX?
The company number of ONCOLOGIX is 1027.890.093. The VAT number is the same number with BE in front: BE 1027.890.093.
Where is ONCOLOGIX based?
The registered office is at Alphonse De Wittestraat 50, 1050 Ixelles.Company details
What does ONCOLOGIX do?
According to the KBO register, the main activity is other research and development on natural sciences (NACE 72109).
What is the legal form of ONCOLOGIX?
ONCOLOGIX is a private limited company (BV).
When was ONCOLOGIX founded?
ONCOLOGIX was founded on 19-09-2025.
Is ONCOLOGIX still active?
Yes, ONCOLOGIX is an active enterprise in the KBO register.
What is the turnover of ONCOLOGIX?
The turnover in financial year 2025 is ≈ €150,000. This figure is estimated from the gross margin of €37,479 and 3,268 comparable companies of the same size. It probably lies between €89,000 and €260,000. It is a rough estimate.Financials
Is ONCOLOGIX profitable?
In financial year 2025, ONCOLOGIX made a profit of €29,775.
Where can I find the annual accounts of ONCOLOGIX?
ONCOLOGIX filed 1 annual account with the National Bank of Belgium, for financial year 2025.

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.